Tag Archives: Takeda

Takeda taps Elektrofi’s microparticle delivery platform for potential subq plasma offerings

Takeda has joined forces with drug delivery specialist Elektrofi to see whether the biotech’s microparticle formulation technology could enable simpler dosing with plasma-derived therapies. Takeda will assess Elektrofi’s drug delivery platform using an undisclosed plasma protein, with the long-term aim of creating and testing high-concentration, low-viscosity samples, Elektrofi said in a release. Elektrofi’s microparticle formulations might eventually allow… Read More »

Takeda says cancer drug Alunbrig shows longer benefit vs. crizotinib

(This Nov. 23rd story corrects fiscal year of expected regulatory approval in the 10th paragraph to March-end 2021, not March-end 2020) FILE PHOTO: Takeda Pharmaceutical Co’s logo is seen at its headquarters in Tokyo, Japan, July 2, 2018. REUTERS/Kim Kyung-Hoon/File Photo By Rocky Swift (Reuters) – Japan’s biggest drugmaker, Takeda Pharmaceutical Co Ltd, said long-term… Read More »